Your search returned 4 results.

Results
	1.	Low tumor cell density environment yields survival advantage of tumor cells exposed to MTX in vitro. [electronic resource] by de Anta, Josep M Real, Francisco X Mayol, Xavier Producer: 20050301 In: Biochimica et biophysica acta vol. 1721 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	The DNA damage checkpoint is activated during residual tumour cell survival to methotrexate treatment as an initial step of acquired drug resistance. [electronic resource] by de Anta, Josep M Pérez-Castro, Antonio J Freire, Raimundo Mayol, Xavier Producer: 20070424 In: Anti-cancer drugs vol. 17 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3.	Methotrexate resistance in vitro is achieved by a dynamic selectionprocess of tumor cell variants emerging during treatment. [electronic resource] by de Anta, Josep M Mayo, Clara Solé, Francesc Salido, Marta Espinet, Blanca Corzo, Cristina Petzold, Myriam Villa, Olaya Serrano, Sergi Real, Francisco X Mayol, Xavier Producer: 20060921 In: International journal of cancer vol. 119 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	4.	The PLAU P141L single nucleotide polymorphism is associated with collateral circulation in patients with coronary artery disease. [electronic resource] by Duran, Joan Sánchez-Olavarría, Pilar Mola, Marina Götzens, Víctor Carballo, Julio Martín-Pelegrina, Eva Petit, Màrius García Del Blanco, Bruno García-Dorado, David de Anta, Josep M Producer: 20150918 In: Revista espanola de cardiologia (English ed.) vol. 67 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)